Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced positive preliminary topline results from its first in …
Read More
WASHINGTON, D.C. — The following quote is attributed to Janet Woodcock, M.D., Acting FDA Commissioner:
Read More
WAYNE, PA — RCH Solutions (RCH), a global provider of Bio-IT computing expertise for Life Sciences and Healthcare firms of all sizes, adds depth to its team of scientific experts with …
Read More
WASHINGTON, D.C. — A web-based COVID-19 outpatient treatment locator maintained by the U.S. Department of Health and Human Services (HHS) is now available to assist healthcare providers and patients in finding potential …
Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the U.S. Food and Drug Administration (FDA) granted clearance for the Company’s TouchStar treatment, a three-minute intermittent theta burst (iTBS) protocol …
Read More
MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, recently provided an update …
Read More WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced its financial results for the third quarter of …
Read More MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced that, after a strategic review …
Read More
The U.S. Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least …
Read MoreThe U.S. Food and Drug Administration recently announced that it has awarded six new clinical trial research grants to principal investigators from academia and industry totaling over $16 million over …
Read More